2020 Practice News
Although Halloween may look a little different this year, you can still make the most of it for your little ghosts and goblins! Be sure to follow safe, socially distanced trick-or-treating guidelines, and join us in participating in FARE’s Teal Pumpkin Project.
This week, Marie McFalls celebrates 40 years with Atlanta Allergy & Asthma!
On Sunday, August 9th, Dr. Kathleen Sheerin joined The Weekly Check-Up Atlanta radio show to discuss back-to-school and fall allergies.
For years, allergists have managed and controlled asthma with long-term control medicines to avoid asthma attacks, and quick-relief, or rescue, medicines to treat symptoms once they start. Allergists can now use a group of prescription drugs, called biologics, developed to treat difficult to control asthma and some skin conditions.
Schools are facing major challenges for the 2020-2021 school year. If your child has nasal allergies, food allergies, or asthma, now is the time to schedule an appointment with your allergist.
Atlanta Allergy & Asthma is now offering PALFORZIA, the first FDA-approved treatment for pediatric patients with peanut allergy.
Mounting evidence supports the value of wearing a face covering to help slow the spread of coronavirus, COVID-19. It is especially important for those with allergies and asthma to wear a mask.
Are you returning to the workplace with concerns about managing your respiratory health? It is important to be familiar with the CDC's safety recommendations for your specific industry.
More than half of Atlanta Allergy & Asthma physicians rank among metro Atlanta’s Top Doctors in Atlanta magazine’s July issue. More than half of the physicians in the publication’s allergy and immunology category come from this one practice.
The tragic events of the past several weeks have saddened us, but it has renewed our commitment to not only seek diversity and inclusion in our own workplace but to root out racism and injustice wherever it may live.
The past several months have been difficult for everyone, and an accurate diagnosis has never been more important. Learn more about the services we offer, and read what our patients have been saying about us during the COVID-19 crisis.
The team at Atlanta Allergy & Asthma continues to monitor daily for new information from the Centers for Disease Control (CDC) and the Georgia Department of Public Health (DPH). For your convenience, we have gathered our past Patient Updates in one place.
For almost 50 years the specialists at Atlanta Allergy & Asthma have served the people of Atlanta and North Georgia and we will be here for you, our patients, through this public health crisis. We have closely monitored the rapidly evolving pandemic and implemented safety measures while still providing care to those who need it.
We are committed to staying open and delivering care to our patients in need during this period. However, we now find it necessary to adjust shot hours during this time. Effective Tuesday April 14th, all Atlanta Allergy & Asthma offices will be closed between noon and 1 pm.
Starting Monday, 3/23, we are rolling out telehealth visits with the goal of greatly reducing the number of patients coming to our offices. We continue to take precautions to promote social distancing and minimize the risk of COVID-19 exposure while still providing care to those that need it.
We have promised to keep you updated during this unprecedented time. One thing has proven true — this is a rapidly evolving public health crisis.
While the coronavirus (COVID-19) outbreak is a rapidly changing and fluid situation from a public health perspective, we are committed to keeping you informed and to taking care of you, our patients.
The physicians at Atlanta Allergy & Asthma are closely monitoring the coronavirus outbreak via the Centers for Disease Control and Prevention (CDC), Georgia Department of Public Health (DPH), and the World Health Organization (WHO). As the virus and protocols around the outbreak are evolving, we are working to protect our patients, providers, and staff.
On Friday, January 31st the U.S. Food and Drug Administration approved the first drug for treatment of peanut allergy for children. Palforzia is indicated for children with peanut allergy to reduce the risk of severe allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.